Startup profile for Q Bio: what they do, why they are interesting, stage (growth), industries, and links to our funding articles. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Q Bio

Quantitative preventive-health platform with full-body MRI and longitudinal biomarkers.

Stage

growth

Status

private

Coverage

full

Why Q Bio is interesting

Stanford's Mike Snyder co-founded; a16z + Khosla backing Tensor Field Mapping scan tech.

Key facts

  • a16z portfolio status: Active
  • Series B (2020): $40M led by a16z; Khosla and Founders Fund on board (Business Wire)
  • Strategic (2024): $27M for Mark I full-body MRI scanner manufacturing (STAT)

Investors in our directory

Funds linked from Q Bio's profile — open a fund page for stage focus and related deal articles.

Industries

Healthtech Biotech & Life Sciences

Industry hub pages are rolling out from our fund-derived baseline taxonomy.

Related funding articles

Venture Capital Tracker pieces that cover Q Bio's financing or category context.

Last updated: 2026-07-24